Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model

Equine Veterinary Journal

Volumn 39, Issue 6, 2007, Pages 491-497

  Long, M T ^a   Gibbs, E P J ^a   Mellencamp, M W ^a   Bowen, R A ^a   Seino, K K ^a   Zhang, S ^a   Beachboard, S E ^a   Humphrey, P P ^a  

^a NONE

Author keywords

Flavivirus chimera; Horse; Intrathecal challenge; West Nile virus; West Nile virus vaccine

Indexed keywords

EQUIDAE; FLAVIVIRUS; WEST NILE VIRUS;

LIVE VACCINE; VIRUS ANTIBODY; WEST NILE VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CHIMERA; DOSE RESPONSE; FEMALE; HORSE; HORSE DISEASE; HOSPITALIZATION; IMMUNOLOGY; MALE; PATHOGENICITY; RANDOMIZATION; SAFETY; TIME; TREATMENT OUTCOME; VIREMIA; VIRULENCE; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

ANIMALS; ANTIBODIES, VIRAL; CHIMERA; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; HORSE DISEASES; HORSES; MALE; RANDOM ALLOCATION; SAFETY; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VACCINES, ATTENUATED; VIREMIA; VIRULENCE; WEST NILE FEVER; WEST NILE VIRUS; WEST NILE VIRUS VACCINES;

EID: 38449119165     PISSN: 04251644     EISSN: None     Source Type: Journal    
DOI: 10.2746/042516407X217416     Document Type: Article

References (22)

1. Anon (1999) Biosafety in Microbiological and Biomedical Laboratories, 4th edn., United States Department of Health and Human Services (HHS) Public Health Service/Centers for Disease Control and Prevention and National Institutes of Health. p 265, Available at: http://www.cdc.gov/od/ ohs/biosfty/bmbl4/bmbl4toc.htm; Accessed 16th September 2006.
2. Anon (2002) Veterinary Services Memorandum No. 800.202. United States Department of Agriculture (USDA) Center for Veterinary Biologics (CVB). Available at: http://www.aphis.usda.gov/vs/cvb/html/vsmemos.html; Accessed 30th June 2006.
3. Arroyo, J., Miller, C., Catalan, J., Myers, G.A., Ratterree, M.S., Trent, D.W. and Monath, T.P. (2004) ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy. J. Virol. 78, 12497-12507.
4. Bowen, R.A., Gordy, P., Mellencamp, M. and Baker, D. (2004) Efficacy of a live attenuated chimeric West Nile virus vaccine in horses against clinical disease following challenge with virulent West Nile virus. In: Supplemental Proceedings of the 53rd Annual Meeting of the American Society of Tropical Medicine and Hygiene. Abstr/Poster 2096.
5. Bunning, M.L., Bowen, R.A., Cropp, C.B., Sullivan, K.G., Davis, B.S., Komar, N., Godsey, M.S., Baker, D., Hettler, D.L., Holmes, D.A., Biggerstaff, B.J. and Mitchell, C.J. (2002) Experimental infection of horses with West Nile virus. Emerg. Infect. Dis. 8, 380-386.
6. Castillo-Olivares, J. and Wood, J. (2004) West Nile virus infection of horses. Vet. Res. 35, 467-483.
7. Clark, D.H. and Casals, J. (1958) Techniques for hemagglutination and hemagglutination-inhibition with arthropod-born viruses. Am. J. trop. Med. Hyg. 7, 561-573.
8. Davidson, A.H., Traub-Dargatz, J.L., Rodeheaver, R.M., Ostlund, E.N., Pedersen, D.D., Moorhead, R.G., Stricklin, J.B., Dewell, R.D., Roach, S.D., Long, R.E., Albers, S.J., Callan, R.J. and Salman, M.D. (2005) Immunologic responses to West Nile virus in vaccinated and clinically affected horses. J. Am. vet. med. Ass. 226, 240.
9. Davis, B.S., Chang, G.J., Cropp, B., Roehrig, J.T., Martin, D.A., Mitchell, C.J., Bowen, R. and Bunning, M.L. (2001) West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J. Virol. 75, 4040-4047.
10. Long, M.T. (2003) Preliminary data regarding the subclinical exposure rate of horses to West Nile virus during the 2001 Florida enzootic. Proc. Am. Ass. equine Practnrs. 49, 397-398.
11. Long, M.T., Gibbs, E.P.J., Mellencamp, M.W., Zhang, S., Barnett, C., Seino, K.S., Beachboard, S.E. and Humphrey, P.P. (2007) Safety of an attenuated West Nile virus vaccine, live Flavivirus chimera in horses. Equine vet. J. 39, 486-490.
12. Minke, J.M., Siger, L., Karaca, K., Austgen, L., Gordy, P., Bowen, R., Renshaw, R.W., Loosmore, S., Audonnet, J.C. and Nordgren, B. (2004) Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge. Arch. Virol. Suppl. 18, 221-230.
13. Monath, T.P., Arroyo, J., Miller, C. and Guirakhoo, F. (2001) West Nile virus vaccine. Curr. Drug Targets Infect. Disord. 1, 37-50.
14. Monath, T.P., Liu, J., Kanesa-Thasan, N., Myers, G.A., Nichols, R., Deary, A., McCarthy, K., Johnson, C., Ermak, T., Shin, S., Arroyo, J., Guirakhaoo, F., Kennedy, J.S., Ennis, F.A., Green, S. and Bedford, P. (2006) A live, attenuated recombinant West Nile virus vaccine. Proc. Natl. Acad. Sci. USA. 103, 10823.
15. Ng, T., Hathaway, D., Jennings, N., Champ, D., Chiang, Y.W. and Chu, H.J. (2003) Equine vaccine for West Nile virus. Dev. Biol. (Basel) 114, 221-227.
16. Ostlund, E.N., Crom, R.L., Pederson, D.D., Johnson, D.J., Williams, W.O. and Schmidt, B.J. (2001) Equine West Nile encephalitis, United States. Emerg. infect. Dis. 7, 665-669.
17. Porter, M.B., Long, M.T., Getman, L.M., Giguere, S., MacKay, R.J., Lester, G.D., Alleman, A.R., Wamsley, H.L., Franklin, R.P., Jacks, S., Buergelt, C.D. and Detrisac, C.J. (2003) West Nile virus encephalomyelitis in horses: 46 cases (2001). J. Am. vet. med. Ass. 222, 1241-1247.
18. Salazar, P., Traub-Dargatz, J.L., Morley, P.S., Wilmot, D.D., Steffen, D.J., Cunningham, W.E. and Salman, M.D. (2004) Outcome of equids with clinical signs of West Nile virus infection and factors associated with death. J. Am. vet. Ass. 225, 267-274.
19. Siger, L., Bowen R., Karaca, K., Murray, M., Jagannatha, S., Echols, B., Nordgren, R. and Minke, J.M. (2006) Evaluation of the efficacy provided by a recombinant canarypox-vectored equine West Nile virus vaccine against an experimental West Nile virus intrathecal challenge in horses. Vet. Ther. 7, 249-256.
20. Siger, L., Bowen, R.A., Karaca, K., Murray, M.J., Gordy, P.W., Loosmore, S.M., Audonnet, J.C., Nordgren, R.M. and Minke, J.M. (2004) Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses. Am. J. vet. Res. 65, 1459-1462.
21. Takasaki, T., Yabe, S., Nerome, R., Ito, M., Yamada, K. and Kurane, I. (2003) Partial protective effect of inactivated Japanese encephalitis vaccine on lethal West Nile virus infection in mice. Vaccine 21, 4514-4518.
22. Tesh, R., Arroyo, J., Travassos Da Rosa, A.P., Guzman, H., Ziao, Sy. and Monath, T.P. (2002) Efficacy of a killed virus vaccine, live attenuated chimeric virus vaccine and passive immunization for prevention of West Nile virus encephalitis in hamster model. Emerg. Infect. Dis. 8, 1392-1397.